Durvalumab Wins FDA Approval in Limited-Stage SCLC

Published Date: 06 Dec 2024

Unprecedented 22.5-month improvement in median overall survival as consolidation therapy

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

2.

Colon cancer and exercise: Can physical activity reprogram genes?

3.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

4.

AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI

5.

When does a melanoma metastasize? Implications for management


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot